Nuclera and leadxpro Partner to Accelerate Structure-based Drug Design for Complex Membrane Proteins
- Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targets
- To de-risk and shorten path to critical structural and biophysical insights that inform structure-based drug design